Cancer Treatment Before and After Physician-Pharmacy Integration
Results of this cohort study indicated that the integration of oncology practices with pharmacies was not associated with significant changes in expenditures or clear patient-centered benefits.
Study: Integration of Pharmacies with Physician Practices Has Little Impact on Cancer Drug Expenditures
Researchers found a slight increase in use of oral cancer drugs, but no significant change in expenditures on the drugs.
Association Between Oral Targeted Cancer Drug Net Health Benefit, Uptake, and Spending
Low- net health benefit (NHB) targeted cancer drugs (TCDs) were prescribed less frequently than medium- and high-net NHB TCDs. Total spending on oral TCDs was high and positively associated with NHB.
USC-Led Study Leverages Artificial Intelligence to Predict Risk of Bedsores in Hospitalized Patients
A new study in BMJ Open presents a new model for predicting patients most at risk of bedsores in hospitals
Analysis of Devices Authorized by the FDA for Clinical Decision Support in Critical Care
This case series study examines the clinical evidence cited for US Food and Drug Administration–approved clinical decision support devices
We Can Find Cancers with a Simple Blood Test
As a cancer researcher and a health economist, we’ve seen up close through our lab and consulting work the revolution contained in a blood draw. But cancer detection blood tests aren’t built into annual physicals like standard blood tests, and so far they aren’t covered by insurance.
USC’s Minority Aging Research Center Secures $3.6M for Alzheimer’s Research
Researchers study the health and economics issues associated with cognitive decline and dementia, and particularly the inequitable burden of Alzheimer’s.
Congress Can Eradicate Hepatitis C and Reduce the Deficit at the Same Time
The initiative comes with a $12.3 billion price tag — and over 10 years, the savings in health care costs will reach $18.1 billion.
Without Early Detection, Fighting Dementia Is an Uphill Battle
A brief assessment in primary care can help identify patients most at risk
Cancer-Related Technologies Have Changed a Lot. So Should Cancer Screening.
Current cancer-screening and reimbursement paradigms should be revised to recognize the value of new technologies available.
The Inflation Reduction Act Is Already Killing Potential Cures
The law’s price controls do away with incentives for research and development of life-saving drugs.
Bumpy Road Ahead for Lecanemab Approval
How to ensure lecanemab doesn’t wind up like aducanumab.
Considerations in the Implementation of Multicancer Early Detection Tests
An analysis of the potential benefits and challenges of multi-cancer blood-based tests.
Largest Medicare Advantage Plans Pay Big Markups for Dialysis
Large dialysis chains charge Medicare Advantage plans 27% more than the traditional, fee-for-service Medicare program.
Rapid Growth in Oncology Practices Directly Dispensing Cancer Drugs
Medically integrated dispensing allows oncology practices to dispense oral anticancer drugs at their practices in onsite pharmacies.
Federal Regulations of Cannabis for Public Health in the United States
State-level cannabis regulations have weak public health parameters compared to other countries, leaving consumers vulnerable.
It’s Time to Let Pharmacists Prescribe COVID-Fighting Pills Like Paxlovid
To reduce hospitalization and death, pharmacists should have the same prescribing abilities as doctors for COVID anti-viral drugs Paxlovid and Lagevrio, USC School of Pharmacy
Dean Vassilios Papadopoulos writes in a new MarketWatch op-ed.
Schaeffer Center Economic Modeling Contributes to National Academy Report on Diversity in Clinical Trials
Populations underrepresented in clinical trials face worse health outcomes that will cost the U.S. trillions of dollars over the next three decades.
USC Schaeffer’s Rocio Ribero Was a Deep Thinker Who Loved Laughter, Her Family and Solving Problems
USC Price is remembering Rocio Ribero, a research scientist who produced groundbreaking work in the Schaeffer Center for Health Policy and Economics.
Improving Care of People with Serious Medical Illness: An Economic Research Agenda for Palliative Care
In 2020, Schaeffer Center established an Advisory Panel on Palliative Care. In this post, the panel outlines next steps to increase the quality of care of frail people with multiple chronic conditions.